4-year overview of pharmacovigilance activities in the EU shows robust and effective medicines safety system

December 17, 2019 – A report on the activities ensuring the safety of medicines carried out by EMA and the national competent authorities of the European Union (EU) Member States, Norway and Iceland from 2015 to 2018 shows that the EU pharmacovigilance system is strong and adaptable and has had a positive impact on public health. The report measures the longer-term impact of the pharmacovigilance legislation, which came into effect in July 2012, in terms of … (leggi tutto)